While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer's disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, ...

(PHILADELPHIA) -While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer's disease, giving patients an amyloid PET scan is not an effective method for measuring their ...

WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, who suffers from Alzheimer's, prepares to receive a PET scan at MedStar Georgetown University Hospital in Washington, DC. (Photo by Michael Robinson Chávez ...

Imatinib (STI571) plus hydroxyurea: Safety and efficacy in pre-treated, progressive glioblastoma multiforme (GBM) patients (pts) No significant financial relationships to disclose. This is an ASCO ...

Correctly distinguishing between related neurodegenerative diseases remains challenging for clinicians, because reliable markers do not yet exist for many disorders. In the July 22 Neurology, ...

Prognostic value of circulation tumor DNA dosing in patients in neoadjuvant breast neoplasia (GIRO-ctDNA). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...

Add Yahoo as a preferred source to see more of our stories on Google. Biologically speaking, there is no organ as vital or complex as the brain. And yet, the brain still remains somewhat a of a ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...

Researchers find fluorodeoxyglucose (FDG) PET is a better indicator of cognitive performance when compared to PET scans that detect amyloid protein. While the presence of beta-amyloid plaques in the ...